{'fraction_non_alphanumeric': 0.026525198938992044, 'fraction_numerical': 0.026525198938992044, 'mean_word_length': 6.075, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transcription of the inositol polyphosphate 1‐phosphatase gene (INPP1) is upregulated in human colorectal cancer

We have used suppression subtractive hybridization to demonstrate significant overexpression of the inositol polyphosphate 1‐phosphatase gene (INPP1) in colorectal cancer compared with matched normal colon epithelium. Its gene product catalyses the hydrolysis of inositol 1,3,4‐trisphosphate and inositol 1,4‐bisphosphate, a key molecule in the phosphoinositide metabolic and signaling pathways. Following confirmation of the differential expression by reverse Northern dot blot analysis, fully quantitative Taqman reverse transcriptase–polymerase chain reaction assays showed that its transcription was upregulated in 42/49 colorectal tumors. There was no significant difference in four tumors and reduced transcription was observed in three. This is the first study to report the upregulation of the INPP1 gene in a human cancer and should facilitate further studies looking at the role of phosphatidylinositol signaling reactions in human colorectal cancer. Mol. Carcinog. 27:322–329, 2000. © 2000 Wiley‐Liss, Inc.